A phase II trial of chemotherapeutic agents in patients with diffuse large B-Cell lymphoma

668695
Cancer - Lymphoma, Cancer
Syed Ali, MD
  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA
The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Newly diagnosed diffuse large B-cell lymphoma expressing CD20 antigen
Active
Interventional (Clinical Trial)
2
Katie Colbeck
413-794-9875